Clinical Trial Update: Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update shows Phase 1/2 testing of PRX302 for lower urinary tract symptoms due to benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• PRX302

Snippet

Sponsor: Sophiris Bio Corp | Conditions: Benign Prostatic Hyperplasia | Phase 1, Phase 2 | Status: COMPLETED